Leveraging the Emergency Department (LEAD) Study
NCT06605534
This study is recruiting at 10 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial. The study will first examine reach in a non-traditional setting (the Emergency Department - ED) that uses an Electronic Health Record (EHR)-embedded Social Determinants of Health (SDoH) screening tool to identify lung screening-eligible patients for a tailored intervention to increase lung screening uptake. Reach is defined as the absolute number, proportion, and representativeness of individuals targeted for lung screening knowledge, awareness, and uptake.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Lung Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 50 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Hackensack Meridian Health
- Last updated on ClinicalTrials.gov
- September 8, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New Jersey · 10
- Ocean Medical Center · Brick, NJ
- John F. Kennedy Medical Center · Edison, NJ
- Hackensack University Medical Center · Hackensack, NJ
- Bayshore Medical Center · Holmdel, NJ
- Southern Ocean Medical Center · Manahawkin, NJ
- Jersey Shore University Medical Center · Neptune City, NJ
- Palisades Medical Center · North Bergen, NJ
- Old Bridge Medical Center · Old Bridge, NJ
- Raritan Bay Medical Center · Perth Amboy, NJ
- Riverview Medical Center · Red Bank, NJ
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.